Last10K.com

Prestige Consumer Healthcare Inc. (PBH) SEC Filing 10-K Annual Report for the fiscal year ending Thursday, March 31, 2022

SEC Filings

PBH Valuations

Intrinsic Value
Financial Stability
Financial Ratios
Insider Trades
Manager Portfolios
Notifications

PBH Annual Reports

10-K Annual Report May 2022
10-K Annual Report May 2021
10-K Annual Report May 2020
10-K Annual Report May 2019
10-K Annual Report May 2018
10-K Annual Report May 2017
10-K Annual Report May 2016
10-K Annual Report May 2015
10-K Annual Report May 2014

PBH Quarterly Reports

10-Q Quarterly Report February 2022
10-Q Quarterly Report November 2021
10-Q Quarterly Report August 2021
10-Q Quarterly Report February 2021
10-Q Quarterly Report November 2020
10-Q Quarterly Report August 2020
10-Q Quarterly Report February 2020
10-Q Quarterly Report October 2019
10-Q Quarterly Report August 2019
10-Q Quarterly Report February 2019

PBH Corporate News

Earnings Release
Financial Exhibit
Other Events
Regulated Disclosure

May 2022
Earnings Release
Financial Exhibit
Regulated Disclosure

February 2022
Earnings Release
Financial Exhibit
Regulated Disclosure

November 2021
Earnings Release
Financial Exhibit
Regulated Disclosure

August 2021
Change in Assets
Financial Exhibit
New Agreement
Regulated Disclosure

July 2021
Earnings Release
Financial Exhibit
Regulated Disclosure

May 2021
Financial Exhibit
New Agreement
New Financial Obligation

March 2021
Earnings Release
Event for Officers
Financial Exhibit
Regulated Disclosure

February 2021
Earnings Release
Financial Exhibit
Regulated Disclosure

November 2020
Earnings Release
Financial Exhibit
Regulated Disclosure

August 2020

Prestige Brands Holdings, Inc.

HISTORY TOOLS
CIK: 1295947 Ticker: PBH

Exhibit 99.1    

Prestige Consumer Healthcare Inc. Reports Record Results for Fiscal 2022

◦Company Exceeds Full-Year Earnings Outlook for Revenue, EPS, and Cash Flow
◦Revenue of $266.9 Million in Q4 and $1,086.8 Million for Full-Year Fiscal 2022, up 12.3% and 15.2% versus Prior Year, respectively
◦Adjusted Diluted EPS of $4.06 for Fiscal 2022, up 25.3% versus Prior Year
◦Net Cash Provided by Operating Activities of $259.9 Million and Record Non-GAAP Free Cash Flow of $253.7 Million in Full-Year Fiscal 2022
◦Initial Full-Year Fiscal 2023 Revenue Outlook of Approximately 3% to 4%
◦Board of Directors Authorizes New $50 million Share Repurchase Program

TARRYTOWN, N.Y.--(GLOBE NEWSWIRE)-May 5, 2022-- Prestige Consumer Healthcare Inc. (NYSE:PBH) today reported financial results for its fourth quarter and fiscal year ended March 31, 2022.

“We are very pleased with our record fiscal 2022 that included double-digit revenue, earnings, and cash flow growth. This performance is the result of our proven business strategy and benefits of our leading portfolio of brands, which enabled us to continue delivering these outstanding results in a dynamic operating environment. The results are a continuation of our long history of delivering value for our stakeholders through successful execution of our business strategy. We look forward to discussing this history of success and what gives us confidence in future growth during tomorrow’s earnings call,” said Ron Lombardi, Chief Executive Officer of Prestige Consumer Healthcare.

Fourth Fiscal Quarter Ended March 31, 2022

Reported revenues in the fourth quarter of fiscal 2022 of $266.9 million increased 12.3% versus $237.8 million in the fourth quarter of fiscal 2021. Revenues increased 5.9% excluding the impact of foreign currency and a $16.3 million contribution from the acquisition of Akorn. The revenue performance for the quarter was driven by continued strong performance across many of the Company’s key brands including improved demand for certain brands, categories and channels that had been impacted by the COVID-19 virus in the prior year fourth quarter such as higher demand for cough & cold products.

Reported net income for the fourth quarter of fiscal 2022 totaled $52.1 million, compared to the prior year quarter’s net income of $35.5 million. Diluted earnings per share of $1.02 for the fourth quarter of fiscal 2022 compared to $0.70 in the prior year comparable period. On a non-GAAP basis, excluding discrete tax items, adjusted net income and adjusted diluted earnings per share in fiscal 2022 of $46.3 million and $0.91 per share, respectively, compared to $39.9 million and $0.79 per share, respectively, in the prior year comparable period.

The adjustment of net income in the fourth quarter fiscal 2022 reflects a tax rate adjustment to account for a discrete benefit associated with a change in the Company’s deferred state tax liabilities. The adjustment of net income in the fourth quarter fiscal 2021 includes a loss on extinguishment of debt and the related income tax effects.

Fiscal Year Ended March 31, 2022

Reported revenues for the fiscal year 2022 totaled $1,086.8 million, an increase of 15.2%, compared to revenues of $943.4 million for the fiscal year 2021. Revenues increased 10.1% excluding the impact of

The following information was filed by Prestige Brands Holdings, Inc. (PBH) on Thursday, May 5, 2022 as an 8K 2.02 statement, which is an earnings press release pertaining to results of operations and financial condition. It may be helpful to assess the quality of management by comparing the information in the press release to the information in the accompanying 10-K Annual Report statement of earnings and operation as management may choose to highlight particular information in the press release.

View differences made from one year to another to evaluate Prestige Brands Holdings, Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Prestige Brands Holdings, Inc..

Continue

Assess how Prestige Brands Holdings, Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Prestige Brands Holdings, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2022 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

Tools

Rating

Learn More
Bullish Bearish Neutral
Filter by Sentiment:
All
Positive
Negative
Filter by Category:
All
Financial
Revenue
M & A
Other
Filter by Subcategory:
All
Debt
Product
Geography
Expense
Earnings
Cash Flow
Other
Inside Prestige Brands Holdings, Inc.'s 10-K Annual Report:

Financial Statements, Disclosures and Schedules

Inside this 10-K Annual Report

Audit Information
Cover Page
Consolidated Balance Sheets
Consolidated Balance Sheets (Parenthetical)
Consolidated Statements Of Cash Flows
Consolidated Statements Of Changes In Stockholders' Equity
Consolidated Statements Of Income And Comprehensive Income
Accumulated Other Comprehensive Loss
Accumulated Other Comprehensive Loss (Details)
Accumulated Other Comprehensive Loss (Tables)
Acquisition
Acquisition (Allocation Of Assets Acquired And Liabilities Assumed) (Details)
Acquisition (Narrative) (Details)
Acquisition (Tables)
Business And Basis Of Presentation
Business And Basis Of Presentation (Cash And Cash Equivalents) (Details)
Business And Basis Of Presentation (Cost Of Sales) (Details)
Business And Basis Of Presentation (Earnings Per Share) (Details)
Business And Basis Of Presentation (Intangible Assets) (Details)
Business And Basis Of Presentation (Leases) (Details)
Business And Basis Of Presentation (Pension Expense) (Details)
Business And Basis Of Presentation (Policies)
Business And Basis Of Presentation (Property, Plant And Equipment) (Details)
Business And Basis Of Presentation (Revenue Recognition) (Details)
Business And Basis Of Presentation (Tables)
Business Segments
Business Segments (Assets By Segment) (Details)
Business Segments (Goodwill And Intangible Assets By Geographic Area) (Details)
Business Segments (Information On Operating And Reportable Segments) (Details)
Business Segments (Revenue By Geographic Area) (Details)
Business Segments (Revenue By Product) (Details)
Business Segments (Tables)
Commitments And Contingencies
Commitments And Contingencies (Long-Term Supply Agreement) (Details)
Commitments And Contingencies (Tables)
Concentrations Of Risk
Concentrations Of Risk (Details)
Derivative Instruments
Derivative Instruments (Fair Value) (Details)
Derivative Instruments (Narrative) (Details)
Derivative Instruments (Schedule Of Derivative Gains And Losses) (Details)
Derivative Instruments And Hedging Activities (Tables)
Employee Retirement Plans
Employee Retirement Plans (Accumulated Other Comprehensive Income (Loss)) (Details)
Employee Retirement Plans (Amounts Recognized In The Balance Sheet) (Details)
Employee Retirement Plans (Category Of Plan Assets) (Details)
Employee Retirement Plans (Expected Benefit Payments) (Details)
Employee Retirement Plans (Expected Return On Plan Assets) (Details)
Employee Retirement Plans (Narrative) (Details)
Employee Retirement Plans (Pension Plans In Excess Of Plan Assets) (Details)
Employee Retirement Plans (Periodic Service Costs) (Details)
Employee Retirement Plans (Tables)
Employee Retirement Plans (Weighted Average Assumptions) (Details)
Fair Value Measurements
Fair Value Measurements (Details)
Fair Value Measurements (Tables)
Goodwill
Goodwill (Narrative) (Details)
Goodwill (Schedule Of Changes) (Details)
Goodwill (Tables)
Income Taxes
Income Taxes (Components Of Deferred Tax Balances) (Details)
Income Taxes (Components Of Provision For Income Taxes) (Details)
Income Taxes (Income Before Continuing Operations) (Details)
Income Taxes (Narrative) (Details)
Income Taxes (Reconciliation Of Effective Tax Rate) (Details)
Income Taxes (Tables)
Income Taxes (Uncertain Tax Liability Activity) (Details)
Intangible Assets
Intangible Assets (Expected Amortization Expense) (Details)
Intangible Assets (Narrative) (Details)
Intangible Assets (Reconciliation Of Activity) (Details)
Intangible Assets (Tables)
Inventories
Inventories (Details)
Inventories (Tables)
Leases
Leases (Additional Information) (Details)
Leases (Lease Cost) (Details)
Leases (Lease Maturities) (Details)
Leases (Narrative) (Details)
Leases (Tables)
Long-Term Debt
Long-Term Debt (Maturities Of Long-Term Debt) (Details)
Long-Term Debt (Narrative 2012 Term Loan And 2012 Abl Revolver) (Details)
Long-Term Debt (Narrative 2013 Senior Notes) (Details)
Long-Term Debt (Narrative 2016 Senior Notes) (Details)
Long-Term Debt (Narrative 2019 And 2021 Senior Notes) (Details)
Long-Term Debt (Narrative Interest Rate Swaps) (Details)
Long-Term Debt (Narrative Redemptions And Restrictions) (Details)
Long-Term Debt (Schedule Of Long-Term Debt) (Details)
Long-Term Debt (Tables)
Other Accrued Liabilities
Other Accrued Liabilities (Details)
Other Accrued Liabilities (Tables)
Property, Plant And Equipment
Property, Plant And Equipment (Details)
Property, Plant And Equipment (Tables)
Schedule Ii Valuation And Qualifying Accounts
Schedule Ii Valuation And Qualifying Accounts (Details)
Share-Based Compensation
Share-Based Compensation (Narrative) (Details)
Share-Based Compensation (Restricted Shares Activity) (Details)
Share-Based Compensation (Stock Based Compensation Information) (Details)
Share-Based Compensation (Stock Option Activity) (Details)
Share-Based Compensation (Stock Option Valuation Assumptions) (Details)
Share-Based Compensation (Tables)
Stockholders' Equity
Stockholders' Equity (Details)
Stockholders' Equity (Schedule Of Shares Repurchased) (Details)
Stockholders' Equity (Tables)
Subsequent Events
Subsequent Events (Details)
Ticker: PBH
CIK: 1295947
Form Type: 10-K Annual Report
Accession Number: 0001295947-22-000015
Submitted to the SEC: Fri May 06 2022 4:20:12 PM EST
Accepted by the SEC: Fri May 06 2022
Period: Thursday, March 31, 2022
Industry: Pharmaceutical Preparations

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/pbh/0001295947-22-000015.htm